HIV: A Strategic Analysis of Therapeutic and Testing Markets

Kalorama Information
March 1, 2006
200 Pages - SKU: KLI1189531
License type:
Table of Contents Search inside this report Related Reports Buy by the Section

To purchase, check the box next to the section then click the "add section to cart" button. Learn more.

HIV A Strategic Analysis of Therapeutic and Testing Markets
  • Executive Summary (pp. 15-27) US $500.00
  • HIV AIDSNature and Epidemiology (pp. 27-103) US $1,682.00
  • Screening and Diagnosis (pp. 103-119) US $750.00
  • HIV/AIDS Therapeutics (pp. 119-177) US $1,301.00
  • Strategic Assessment of HIV AIDS (pp. 177-209) US $950.00
  • Glossary (pp. 209-241) US $789.00
  • Companies Active in HIV AIDS Therapeutics and Diagnostics (pp. 241-250) US $119.00


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


AIDS, HIV & STDs Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!